Kontakte:Errol Zhou (Mesye.)
Tel: plis 86-551-65523315
Mobile/WhatsApp: plis 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Imèl:sales@homesunshinepharma.com
Ajoute:1002, Huanmao Bilding, No.105, Mengcheng Wout, Hefei Vil, 230061, Lachin

CAS NON: 135046-48-9
Molekile Fomil: C16H18ClNO6S2
Molekile pwa: 419,90
EINECS NON: 603-890-4
MDL NON: MFCD00876395
Pwodwi deskripsyon
Non pwodwi: Clopidogrel bisulfate CAS pa: 135046-48-9
Synonyms:
Clopidogrel Idwojen silfat;
Méthyle (2S)-(2-chlorophenyl) (6, 7-dihydrothieno [3, 2-c] pyridin-5 (4H)-yl) D' silfat;
Thieno [3, 2-c] piridin-5 (4H)-acetic asid, α-(2-chlorophenyl)-6, 7-dihydro-, méthyle ester, (αS)-, silfat (1:1);
(+)-Clopidogrel idwojen silfat;
(Yo)-(+)-Méthyle (2-chlorophenyl) (6, 7-dihydro-4H-thieno [3, 2-c] pyrid-5-yl) D' bisulfate;
Chimik & pwopriyete fizik
Aparans: blan pou koupe-blan cristalline poud
Épreuves: ≥ 99%
Ki ap fonn pwen: 184 ° c
Bouyi pwen: 423.7 ° c nan 760 mmHg
Flash pwen: 210 ° c
Solubility: DMSO: ~ 26mg/mL
Tronbozi ki te koze pa ateryel atheromatous tat mennen nan egi tronbozi kadyovaskile ak serebwo evenman yo. Nan pathogenesis sa a, plaket jwe yon wol santral, ki te konpletman etidye.
Clopidogrel idwojen silfat se menm jan ak ticlopidine, ki se yon nouvo Dwog anti-Feb agrégation, avek sikse devlope pa franse Sanofi-Sythelabo Fort pou prevansyon ak tretman nan ke, sevo ak lot maladi sikilasyon ateryel ki te koze pa ki wo a san yo pa agrégation, tankou aparisyon ki sot pase nan konjesyon serebral, enfaktis myokad ak pasyan dyagnostike ak periferik maladi ateryel. Anpil peyi te deja itilize li, ki gen ladan Lezetazini, Ewop ak Lachin. Pwodwi sa a jennen a te deklanchman aktivasyon pa anpeche adenosine di(ADP) chemen pou empêcher agrégation. Depi clopidogrel idwojen silfat pran plizye jou pou reyalize konsantrasyon san efektif, li pa aplike pou tretman ijans. Sispann itilize 7 pou jou 10, fonksyon an te retounen nan eta nomal.
Si ou enterese nan pwodwi nou yo oswa gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!
Pwodwi anba patant yo ofri pou R & D objektif selman. Sepandan, responsablite final la manti selman avek achte a.
Baj popilè: clopidogrel bisulfate cas pa gen 135046-48-9, manifaktire, founise, faktori, achte, nan Stock